Catalyst Wire Dossier Catalyst Wire Dossier

Varisolve

polidocanol endovenous microfoam (PEM) · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Varisolve, covering 2014-02-26 to 2014-04-02. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose Veins [Phase 2]

See pricing